Filing Details

Accession Number:
0001209191-18-043567
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-20 20:00:23
Reporting Period:
2018-07-19
Accepted Time:
2018-07-20 20:00:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
876378 Transenterix Inc. TRXC Surgical & Medical Instruments & Apparatus (3841) 112962080
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1246530 P Joseph Slattery C/O Transenterix, Inc.
635 Davis Drive, Suite 300
Morrisville NC 27560
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-07-19 56,622 $5.00 0 No 4 S Direct
Common Stock Acquisiton 2018-07-19 8,458 $1.42 8,458 No 4 M Direct
Common Stock Acquisiton 2018-07-19 2,083 $2.45 10,541 No 4 M Direct
Common Stock Acquisiton 2018-07-19 5,625 $2.94 16,166 No 4 M Direct
Common Stock Acquisiton 2018-07-19 6,875 $3.82 23,041 No 4 M Direct
Common Stock Acquisiton 2018-07-19 9,736 $3.94 32,777 No 4 M Direct
Common Stock Acquisiton 2018-07-19 34,999 $4.02 67,776 No 4 M Direct
Common Stock Disposition 2018-07-19 67,776 $5.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2018-07-19 8,485 $0.00 8,458 $1.42
Common Stock Stock Options Disposition 2018-07-19 2,083 $0.00 2,083 $2.45
Common Stock Stock Options Disposition 2018-07-19 5,625 $0.00 5,625 $2.94
Common Stock Stock Options Disposition 2018-07-19 6,875 $0.00 6,875 $3.82
Common Stock Stock Options Disposition 2018-07-19 9,736 $0.00 9,736 $3.94
Common Stock Stock Options Disposition 2018-07-19 34,999 $0.00 34,999 $4.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
262,209 2027-02-02 No 4 M Direct
33,334 2025-10-28 No 4 M Direct
39,376 2025-02-04 No 4 M Direct
130,625 2026-02-12 No 4 M Direct
0 2024-05-27 No 4 M Direct
465,001 2024-04-21 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,000 Indirect By IRA
Footnotes
  1. The transaction occurred pursuant to a written trading plan dated November 29, 2017 meeting the requirements of Rule 10b5-1(c).
  2. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.035 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  3. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.005 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  4. Following the sales on July 19, 2018, the reporting person continues to beneficially own 25,000 shares of the company's common stock. The reporting person also holds stock options to acquire 1,819,045 shares of common stock, of which approximately 26% are vested, and restricted stock units representing an additional 595,777 shares of common stock subject to forfeiture restrictions.
  5. Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan.
  6. Previously vested.